EndoChoice

company

About

EndoChoice, a platform-technology firm, provides devices, diagnostics and infection control for treating gastrointestinal diseases.

  • 251 - 500

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$43M
Industries
Biotechnology,Health Care,Health Diagnostics,Manufacturing
Founded date
Jan 1, 2008
Number Of Employee
251 - 500
Operating Status
Active

EndoChoice is a medtech company focused on the manufacturing and commercialization of platform technologies including devices, diagnostics, infection control and endoscopic imaging for specialists treating a wide range of gastrointestinal (GI) diseases. EndoChoice leverages its direct sales organization to serve more than 2,000 customers in the United States and works with 34 distribution partners world-wide. The Company was founded in 2008 and has rapidly developed a proprietary product portfolio, which includes the revolutionary Full Spectrum Endoscopy™ System (Fuse™). The Fuse System is comprised of colonoscopes and gastroscopes with multiple imagers so doctors can see more of the GI tract for diagnosis and treatment. The Fuse colonoscope provides a field of view of 330 degrees versus 170 degrees from traditional endoscopes. In clinical studies, Fuse found 70% more polyps than traditional colonoscopies. 2013 marked the fourth consecutive year EndoChoice was recognized as one of the fastest growing companies in the U.S. by Inc. Magazine. To learn more, visit www.endochoice.com

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$43M
EndoChoice has raised a total of $43M in funding over 2 rounds. Their latest funding was raised on Jan 4, 2013 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 4, 2013 Series Unknown $43M 1 Sequoia Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
EndoChoice is funded by 1 investors. Sequoia Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Sequoia Capital Yes Series Unknown